Tag Archives: Announces

In movement toward awareness, Taraji P. Henson announces mental health conference

Actress Taraji P. Henson attends The 2016 InStyle And Warner Bros. 73rd Annual Golden Globe Awards Post-Party at The Beverly Hilton Hotel on January 10, 2016 in Beverly Hills, California. (Photo by Jason Merritt/Getty Images for InStyle) As the country observes Mental Health Awareness Month through May, Empire star Taraji P. Henson is announcing a… Read More »

BCG’s INVERTO announces new Managing Director and plans to accelerate UK growth

INVERTO, Boston Consulting Group’s procurement focused subsidiary, is expanding its UK presence as companies continue to manage growth, economic uncertainty and supply chain disruption LONDON, 8 March – INVERTO, one of Europe’s leading procurement and supply chain management consultancies, and a subsidiary of Boston Consulting Group (BCG), is announcing UK expansion plans to help companies… Read More »

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of Apadaz (4.08 mg benzhydrocodone/325 mg APAP and 8.16 mg benzhydrocodone/325 mg APAP)

Print this page CORALVILLE, Iowa, Jan. 07, 2019 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) for two additional strengths of Apadaz, an immediate release (IR)… Read More »